KROS — Keros Therapeutics, Inc. stock price, charts and financials

QT34Keros Therapeutics, Inc.

Keros Therapeutics, Inc. (NASDAQ: KROS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
10.25
+0.14+1.38%
OverviewShort InterestFilings
KROSQT34Keros Therapeutics, Inc.·NASDAQ
10.25+1.38%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20268-KCurrent report
Jul 17, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 01, 20268-KCurrent report
May 19, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 14, 202610-QQuarterly report
#1 / 25 of 361
Page
▼
/ 15